Cordis Us Corporation14201 N W 60th Avenuemiami Lakes Fl 33014 Pma Numberp100013 Supplement Numbers024 Date Received01 31 2022 Decision Date03 01 2022 Product Code Mgb Advisory Committee Cardiovascular Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Cordis Us Corporation14201 N W 60th Avenuemiami Lakes Fl 33014 Pma Numberp100013 Supplement Numbers024 Date Received01 31 2022 Decision Date03 01 2022 Product Code Mgb Advisory Committee Cardiovascular Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P100013S024 Cordis US Corporation14201 N.w. 60th Avenuemiami Lakes, FL 33014 PMA NumberP100013 Supplement NumberS024 Date Received01/31/2022 Decision Date03/01/2022 Product Code MGB  Advisory Committee Cardiovascular Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No	Cordis® Exoseal® Vascular Closure	2022-03-01